AIDS, HIV & STDs Market Research Reports & Industry Analysis
HIV (human immunodeficiency virus) is a virus that attacks the immune system, making it difficult for the body to fight off infection and diseases. HIV infection eventually results in AIDS (acquired immunodeficiency syndrome). This conversion to AIDS may result after 12 or 13 years after the initial infection. Initial HIV symptoms are similar to those of the flu and include fatigue, fever, weight loss, and swollen lymph nodes in the neck, armpits, or groin. Although there is currently no cure for HIV infection, a combination of medications called Highly Active AntiRetroviral Therapy (HAART), and now referred to as AART, helps prolong life in many people. As noted above, person with HIV infection may live for many years before developing any signs of AIDS.
While HIV/AIDS isn’t found in the headlines as much as during the disease’s discovery, more people in the United States are living with HIV/AIDS than ever before. While the incidence of HIV infection in the United States was approximately 0.25% of the population ten to fifteen years ago, it is now approximately 0.47% -- and the population in general has grown.
For this reason, it is important to understand the trends in HIV/AIDS epidemiology and the potential impacts on economies and societies as a whole. These trends emphasize the strategic need for preventive approaches, clinical testing technologies and products, and new therapeutics. Many market research reports provide such information.
AIDS, HIV & STDs Industry Research & Market Reports
-
Immunomodulators Market, by Product Type (Immunosuppressants (Calcineurin Inhibitors, Glucocorticoids, Antimetabolites, and Others), Immunostimulants (Vaccines, Antibodies, and Others)), by Application (Oncology, Respiratory, HIV, and Others), by End User
... (North America, Europe, Asia Pacific, Middle East, Africa, and Latin America) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028 Immunomodulators are medications that either stimulate or inhibit the immune system. They affect the ... Read More
-
2021-2025 U.S. Infectious Disease Testing Market - Growth Opportunities, Supplier Shares by Test, Segmentation Forecasts for 100 Respiratory, STD, Enteric, and other Virology and Bacteriology Assays - Competitive Strategies and SWOT Analysis, Latest Techn
... Instrumentation Pipeline, Market Barriers and Risks This unique report from LeadingMarketResearch.com provides data and analysis not available from any other published source , including test volume and sales forecasts for 100 individual tests, and competitor ... Read More
-
Global Kaposi Sarcoma Market - 2021-2028
... growing at a CAGR of XX % during the forecast period (2021-2028). • Kaposi sarcoma refers to a type of cancer that develops from the cells lining blood vessels or lymph nodes. The cancer usually ... Read More
-
Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Market Research Report 2021-2025
... In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Report by Material, Application, and ... Read More
-
RNA Targeting Small Molecules Therapeutics Market by Type of Target Molecule (Cap Binding Complex, CDKL5, Dystrophin Protein, Era, G542X, MNK1 / MNK2, PAX6 gene, SMN2), Type of Approach (Indirect RNA Targeting- Epitranscriptomics, mRNA Translation Modulat
... Modulation, RNA Splicing Modification), Target Indication (Aniridia, Breast Cancer, Castrate-resistant Prostate Cancer, Colorectal Cancer, Crohn Disease, Cystic Fibrosis, Duchenne Muscular Dystrophy, Dravet Syndrome, Epilepsy, HIV Infections, Impaired Renal Function, Non-Small Cell Lung Cancer, Rheumatoid Arthritis, ... Read More
-
Genital Herpes (Infectious Disease) - Drugs In Development, 2021
... (Infectious Disease) pipeline landscape. Genital herpes is a common sexually transmitted infection that affects both men and women. Genital herpes is caused by the herpes simplex virus (HSV). Symptoms include decreased appetite, fever, general sick ... Read More
-
Herpes Zoster (Shingles) (Infectious Disease) - Drugs In Development, 2021
... Zoster (Infectious Disease) pipeline landscape. Shingles (herpes zoster) is a painful, blistering skin rash. It is caused by the varicella-zoster virus. Symptoms may include fever and chills, headache, joint pain and swollen glands. The predisposing ... Read More
-
Human Immunodeficiency Virus (HIV) Infections (AIDS) (Infectious Disease) - Drugs In Development, 2021
... 2021, provides an overview of the Human Immunodeficiency Virus (HIV) Infections (AIDS) (Infectious Disease) pipeline landscape.HIV is a virus which attacks the immune system, and weakens ability to fight infections and disease. Symptoms include fever, ... Read More
-
Global Chlamydia Infection Treatment Market Growth (Status and Outlook) 2021-2026
... of global Chlamydia Infection Treatment market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Chlamydia Infection ... Read More
-
Chlamydia Infections (Infectious Disease) - Drugs In Development, 2021
... (Infectious Disease) pipeline landscape. Chlamydia is a sexually transmitted infection caused by a bacterium. Symptoms include burning feeling during urination, discharge from the penis or vagina, pain in the lower abdomen, bleeding between periods and ... Read More
-
Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Market Growth 2021-2026
... previous year. By the most conservative estimates of global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ ... Read More
-
Global Herpes Simplex Virus (HSV) Vaccines Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
... and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, ... Read More
-
2021 US Molecular Diagnostics Market Assessment: Supplier Shares and Sales Segment Forecasts
... and other applications. Sales forecasts for HIV, Hepatitis (A, B, C), Parvovirus B19 and West Nile Virus. Sales and market shares for major suppliers of molecular diagnostics and NAT assays. Contains 5 pages Please note: ... Read More
-
Gonorrhea - Global Clinical Trials Review, H2, 2021
... data relating to the clinical trials on Gonorrhea. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by ... Read More
-
U.S. Liposomal Doxorubicin Market, by Drug Type (Branded and Generic), by Cancer Type (Ovarian Cancer, AIDS-related Kaposi’s Sarcoma, Multiple Myeloma, and Others), and by States (California, Texas, Florida, New York, Pennsylvania, Illinois, Ohio, Georgia
... North Carolina, Michigan, New Jersey, Virginia, Washington, Arizona, and Others) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027 Liposomal doxorubicin is a chemotherapy drug, which is administered intravenously to treat AIDS-related Kaposi's sarcoma, ... Read More
-
2021 Syphilis Diagnostics Market: USA, Europe, Japan - Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment - Hospitals, Blood Banks, Commercial and Public Health Labs, POC Locations
... test volumes, sale forecasts and supplier shares for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for Syphilis tests performed in the following market segments: - ... Read More
-
2021 Herpes Molecular Diagnostics Market: USA, Europe, Japan - Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment - Hospitals, Commercial and Public Health Labs, POC Locations
... volumes, sale forecasts and supplier shares for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for Herpes Simplex I/II and Herpes Type VI tests performed in ... Read More
-
2021 Germany HIV/AIDS Molecular Diagnostic Testing Market: Shares and Segment Forecasts - HIV 1/2, Combo, Ag, NAT, Western Blot, Other Confirmatory Tests
... Germany. The report provides test volume and sales forecasts for HIV/HIV-1/2/Combo, HIVAg/HIV , NAT , Western Blot, HTLV-I/II and other confirmatory tests performed in the following market segments: - Hospitals - Commercial/Private Laboratories - Blood ... Read More
-
2021 Italy HIV/AIDS Molecular Diagnostic Testing Market: Shares and Segment Forecasts - HIV 1/2, Combo, Ag, NAT, Western Blot, Other Confirmatory Tests
... Italy. The report provides test volume and sales forecasts for HIV/HIV-1/2/Combo, HIVAg/HIV , NAT , Western Blot, HTLV-I/II and other confirmatory tests performed in the following market segments: - Hospitals - Commercial/Private Laboratories - Blood ... Read More
-
2021 UK HIV/AIDS Molecular Diagnostic Testing Market: Shares and Segment Forecasts - HIV 1/2, Combo, Ag, NAT, Western Blot, Other Confirmatory Tests
... UK. The report provides test volume and sales forecasts for HIV/HIV-1/2/Combo, HIVAg/HIV , NAT , Western Blot, HTLV-I/II and other confirmatory tests performed in the following market segments: - Hospitals - Commercial/Private Laboratories - Blood ... Read More
-
2021 USA HIV/AIDS Molecular Diagnostic Testing Market: Shares and Segment Forecasts - HIV 1/2, Combo, Ag, NAT, Western Blot, Other Confirmatory Tests
... the US. The report provides test volume and sales forecasts for HIV/HIV-1/2/Combo, HIVAg/HIV NAT , Western Blot, HTLV-I/II and other confirmatory tests performed in the following market segments: - Hospitals - Commercial/Private Laboratories - Blood ... Read More
-
Global Antiviral Drugs Market - 2021-2028
... CAGR of XX % during the forecast period (2021-2028). Antiviral drugs are medicines which are used specially for treating viral infections. Most anti-viral drugs are used for particular viral infections, similar to antibiotics, while a ... Read More
-
2021 HIV/AIDS Molecular Diagnostics Market: USA, Europe, Japan - Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment - Hospitals, Blood Banks, Commercial and Public Health Labs, POC Locations
... report presents test volumes, sale forecasts and supplier shares for the US, Europe (France, Germany, Italy, Spain, UK) and Japan for HIV-1/2/Combo, HIV Ag, Western Blot and other confirmatory assays performed in the following markets: ... Read More
-
2021 Gonorrhea Molecular Diagnostics Market: USA, Europe, Japan - Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment - Hospitals, Commercial and Public Health Labs, POC Locations
... volumes, sale forecasts and supplier shares for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for Gonorrhea tests performed in the following market segments: - Birth ... Read More
-
2021 France HIV/AIDS Molecular Diagnostic Testing Market: Shares and Segment Forecasts - HIV 1/2, Combo, Ag, NAT, Western Blot, Other Confirmatory Tests
... France. The report provides test volume and sales forecasts for HIV/HIV-1/2/Combo, HIVAg/HIV , NAT , Western Blot, HTLV-I/II and other confirmatory tests performed in the following market segments: - Hospitals - Commercial/Private Laboratories - Blood ... Read More
Research Assistance
